530 related articles for article (PubMed ID: 21530483)
21. Acetoacetate activation of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase in primary cultured rat hepatocytes: role of oxidative stress.
Abdelmegeed MA; Kim SK; Woodcroft KJ; Novak RF
J Pharmacol Exp Ther; 2004 Aug; 310(2):728-36. PubMed ID: 15051799
[TBL] [Abstract][Full Text] [Related]
22. The TIR/BB-loop mimetic AS-1 prevents cardiac hypertrophy by inhibiting IL-1R-mediated MyD88-dependent signaling.
Zhu Y; Li T; Song J; Liu C; Hu Y; Que L; Ha T; Kelley J; Chen Q; Li C; Li Y
Basic Res Cardiol; 2011 Sep; 106(5):787-99. PubMed ID: 21533832
[TBL] [Abstract][Full Text] [Related]
23. Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic airways.
Liu W; Liang Q; Balzar S; Wenzel S; Gorska M; Alam R
J Allergy Clin Immunol; 2008 Apr; 121(4):893-902.e2. PubMed ID: 18395552
[TBL] [Abstract][Full Text] [Related]
24. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.
Sanna B; Bueno OF; Dai YS; Wilkins BJ; Molkentin JD
Mol Cell Biol; 2005 Feb; 25(3):865-78. PubMed ID: 15657416
[TBL] [Abstract][Full Text] [Related]
25. ERK1/2 and p38 mitogen-activated protein kinase mediate iNOS-induced spinal neuron degeneration after acute traumatic spinal cord injury.
Xu Z; Wang BR; Wang X; Kuang F; Duan XL; Jiao XY; Ju G
Life Sci; 2006 Oct; 79(20):1895-905. PubMed ID: 16978658
[TBL] [Abstract][Full Text] [Related]
26. Antiplatelet effect of AMP-activated protein kinase activator and its potentiation by the phosphodiesterase inhibitor dipyridamole.
Liu Y; Oh SJ; Chang KH; Kim YG; Lee MY
Biochem Pharmacol; 2013 Oct; 86(7):914-25. PubMed ID: 23876340
[TBL] [Abstract][Full Text] [Related]
27. Mechanical stress-mediated Runx2 activation is dependent on Ras/ERK1/2 MAPK signaling in osteoblasts.
Kanno T; Takahashi T; Tsujisawa T; Ariyoshi W; Nishihara T
J Cell Biochem; 2007 Aug; 101(5):1266-77. PubMed ID: 17265428
[TBL] [Abstract][Full Text] [Related]
28. AICAR Enhances the Phagocytic Ability of Macrophages towards Apoptotic Cells through P38 Mitogen Activated Protein Kinase Activation Independent of AMP-Activated Protein Kinase.
Quan H; Kim JM; Lee HJ; Lee SH; Choi JI; Bae HB
PLoS One; 2015; 10(5):e0127885. PubMed ID: 26020972
[TBL] [Abstract][Full Text] [Related]
29. AMP-activated protein kinase activation modulates progesterone secretion in granulosa cells from hen preovulatory follicles.
Tosca L; Crochet S; Ferré P; Foufelle F; Tesseraud S; Dupont J
J Endocrinol; 2006 Jul; 190(1):85-97. PubMed ID: 16837613
[TBL] [Abstract][Full Text] [Related]
30. Multiple signalling pathways underlie the protective effect of levosimendan in cardiac myocytes.
Markou T; Makridou Z; Galatou E; Lazou A
Eur J Pharmacol; 2011 Sep; 667(1-3):298-305. PubMed ID: 21664904
[TBL] [Abstract][Full Text] [Related]
31. 5-Aminoimidazole-4-carboxyamide-ribonucleoside (AICAR)-stimulated hepatic expression of Cyp4a10, Cyp4a14, Cyp4a31, and other peroxisome proliferator-activated receptor α-responsive mouse genes is AICAR 5'-monophosphate-dependent and AMP-activated protein kinase-independent.
Bumpus NN; Johnson EF
J Pharmacol Exp Ther; 2011 Dec; 339(3):886-95. PubMed ID: 21896918
[TBL] [Abstract][Full Text] [Related]
32. Stimulation of cardiomyogenesis of embryonic stem cells by nitric oxide downstream of AMP-activated protein kinase and mTOR signaling pathways.
Padmasekar M; Sharifpanah F; Finkensieper A; Wartenberg M; Sauer H
Stem Cells Dev; 2011 Dec; 20(12):2163-75. PubMed ID: 21470048
[TBL] [Abstract][Full Text] [Related]
33. Activation of AMPK inhibits cardiomyocyte hypertrophy by modulating of the FOXO1/MuRF1 signaling pathway in vitro.
Chen BL; Ma YD; Meng RS; Xiong ZJ; Wang HN; Zeng JY; Liu C; Dong YG
Acta Pharmacol Sin; 2010 Jul; 31(7):798-804. PubMed ID: 20581852
[TBL] [Abstract][Full Text] [Related]
34. Dissociation of AMP-activated protein kinase and p38 mitogen-activated protein kinase signaling in skeletal muscle.
Ho RC; Fujii N; Witters LA; Hirshman MF; Goodyear LJ
Biochem Biophys Res Commun; 2007 Oct; 362(2):354-9. PubMed ID: 17709097
[TBL] [Abstract][Full Text] [Related]
35. Tumor suppressor gene ING3 induces cardiomyocyte hypertrophy via inhibition of AMPK and activation of p38 MAPK signaling.
Wang J; Liu Z; Feng X; Gao S; Xu S; Liu P
Arch Biochem Biophys; 2014 Nov; 562():22-30. PubMed ID: 25151306
[TBL] [Abstract][Full Text] [Related]
36. AMP-activated protein kinase activates p38 mitogen-activated protein kinase by increasing recruitment of p38 MAPK to TAB1 in the ischemic heart.
Li J; Miller EJ; Ninomiya-Tsuji J; Russell RR; Young LH
Circ Res; 2005 Oct; 97(9):872-9. PubMed ID: 16179588
[TBL] [Abstract][Full Text] [Related]
37. The effect of 5-aminoimidazole-4-carboxamide-ribonucleoside was mediated by p38 mitogen activated protein kinase signaling pathway in FRO thyroid cancer cells.
Kim WG; Choi HJ; Kim TY; Shong YK; Kim WB
Korean J Intern Med; 2014 Jul; 29(4):474-81. PubMed ID: 25045295
[TBL] [Abstract][Full Text] [Related]
38. Effects of ERK1/2/PPARα/SCAD signal pathways on cardiomyocyte hypertrophy induced by insulin-like growth factor 1 and phenylephrine.
Huang Q; Huang J; Zeng Z; Luo J; Liu P; Chen S; Liu B; Pan X; Zang L; Zhou S
Life Sci; 2015 Mar; 124():41-9. PubMed ID: 25636810
[TBL] [Abstract][Full Text] [Related]
39. Leptin-induced cardiomyocyte hypertrophy reveals both calcium-dependent and calcium-independent/RhoA-dependent calcineurin activation and NFAT nuclear translocation.
Rajapurohitam V; Izaddoustdar F; Martinez-Abundis E; Karmazyn M
Cell Signal; 2012 Dec; 24(12):2283-90. PubMed ID: 22917533
[TBL] [Abstract][Full Text] [Related]
40. Stimulation of glucose transport in response to activation of distinct AMPK signaling pathways.
Jing M; Cheruvu VK; Ismail-Beigi F
Am J Physiol Cell Physiol; 2008 Nov; 295(5):C1071-82. PubMed ID: 18701654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
